Cargando…

Influence of age on predictiveness of genetic risk score for prostate cancer in a Chinese hospital-based biopsy cohort

BACKGROUND: We investigated whether age influences the predictiveness of genetic risk score (GRS) for prostate cancer (PCa) in a Chinese hospital-based biopsy cohort. METHODS: We included consecutive patients who underwent prostate biopsies in two tertiary centers between 2012 and 2014. GRS was calc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yao, Han, Cheng-Tao, Chen, Hai-Tao, Liu, Fang, Zhang, Gui-Ming, Yang, Wei-Yi, Xu, Jian-Feng, Ye, Ding-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673214/ https://www.ncbi.nlm.nih.gov/pubmed/26011940

Ejemplares similares

Association Between the Body Mass Index and Prostate Cancer at Biopsy is Modified by Genetic Risk: A Cross-Sectional Analysis in China
por: Zhang, Gui-Ming, et al.
Publicado: (2015)

Waist-hip Ratio (WHR), a Better Predictor for Prostate Cancer than Body Mass Index (BMI): Results from a Chinese Hospital-based Biopsy Cohort
por: Tang, Bo, et al.
Publicado: (2017)

Prostate cancer antigen 3 and genetic risk score as markers for the detection of prostate cancer in the Chinese population
por: Wei, Han-Min, et al.
Publicado: (2015)

Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4–10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD Score
por: Fang, Dong, et al.
Publicado: (2015)

The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy
por: Ruan, Xiaohao, et al.
Publicado: (2023)

The association between metabolic syndrome and advanced prostate cancer in Chinese patients receiving radical prostatectomy
por: Zhang, Gui-Ming, et al.
Publicado: (2015)

Genetic variants in RTEL1 influencing telomere length are associated with prostate cancer risk
por: Gu, Cheng-Yuan, et al.
Publicado: (2019)

A Germline Variant at 8q24 Contributes to the Serum p2PSA Level in a Chinese Prostate Biopsy Cohort
por: Lin, Xiaoling, et al.
Publicado: (2021)

Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonography
por: Yu, Guo-Peng, et al.
Publicado: (2016)

Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2015)

Use of RENAL Nephrometry Scores for Predicting Tumor Upgrading Between Core Biopsies and Surgical Specimens: A Prospective Ex Vivo Study
por: Zhang, Gui-Ming, et al.
Publicado: (2015)

Causes and Factors Associated with Frequent Hospitalization in Chinese Patients with Systemic Lupus Erythematosus: An Ambispective Cohort Study
por: Liang, Han, et al.
Publicado: (2019)

Development and external validation of a prostate health index-based nomogram for predicting prostate cancer
por: Zhu, Yao, et al.
Publicado: (2015)

Factors Influencing Aspirin Hyporesponsiveness in Elderly Chinese Patients
por: Ou, Wei mei, et al.
Publicado: (2019)

Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
por: de Lima, Nelson Gianni, et al.
Publicado: (2013)

Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification
por: Davik, Petter, et al.
Publicado: (2022)

Combination of PI-RADS score and PSAD can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies
por: Wang, Changming, et al.
Publicado: (2022)

Two-micrometer thulium laser resection of the prostate-tangerine technique in benign prostatic hyperplasia patients with previously negative transrectal prostate biopsy
por: Zhuo, Jian, et al.
Publicado: (2017)

Influence of age on seven putative prostate tumor markers: a cohort study in Chinese men
por: Sun, Wei-Gui, et al.
Publicado: (2017)

The predictive efficacy of hypoechoic lesion in ultrasound for prostate cancer in Chinese people: five-year experience in a moderated 10-core transperineal prostate biopsy procedure
por: Yang, Tian, et al.
Publicado: (2017)

Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population
por: Zhou, Feng, et al.
Publicado: (2016)

Ultrasound‐based radiomics score for pre‐biopsy prediction of prostate cancer to reduce unnecessary biopsies
por: Ou, Wei, et al.
Publicado: (2022)

Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation
por: He, Biming, et al.
Publicado: (2016)

Development and validation of a nomogram including lymphocyte-to-monocyte ratio for initial prostate biopsy: a double-center retrospective study
por: Zhou, Zhong-Han, et al.
Publicado: (2020)

Presence of HPV in prostate tissue from patients submitted to prostate biopsy
por: Pereira, Nalisson Marques, et al.
Publicado: (2023)

Prevalence and genetic–phenotypic characteristics of patients with USH2A mutations in a large cohort of Chinese patients with inherited retinal disease
por: Gao, Feng-Juan, et al.
Publicado: (2021)

Investigating association of perineural invasion on prostate biopsy with Gleason score upgrading at prostatectomy: A multi‐institutional analysis
por: Barsky, Andrew R., et al.
Publicado: (2020)

Comparison of diagnostic efficacy between transrectal and transperineal prostate biopsy: a propensity score-matched study
por: Jiang, Chen-Yi, et al.
Publicado: (2019)

Genetic variations of the ADIPOQ gene and risk of prostate cancer in Chinese Han men
por: Gu, Cheng-Yuan, et al.
Publicado: (2014)

Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system
por: Alqahtani, Saeed, et al.
Publicado: (2020)

Prognostic significance of the TREK-1 K2P potassium channels in prostate cancer
por: Zhang, Gui-Ming, et al.
Publicado: (2015)

AB189. Prevalence and risk factors of prostate cancer in Chinese men with PSA 4–10 ng/mL underwent TRUS-guided prostate biopsy: the utilization of PAMD score
por: Fang, Dong, et al.
Publicado: (2016)

Effect of Body mass index on the performance characteristics of PSA-related markers to detect prostate cancer
por: Zhu, Yao, et al.
Publicado: (2016)

Outcomes and Trends of Prostate Biopsy for Prostate Cancer in Chinese Men from 2003 to 2011
por: Na, Rong, et al.
Publicado: (2012)

Impact of Benign Prostatic Hyperplasia Pharmacological Treatment on Transrectal Prostate Biopsy Adverse Effects
por: Zamuner, Marina, et al.
Publicado: (2014)

Strain Elastography-Targeted Biopsy: Does Prostate Volume Affect Prostate Cancer Detection?
por: Zhu, Yi-Cheng, et al.
Publicado: (2019)

Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(−1)
por: Chen, Rui, et al.
Publicado: (2015)

Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients
por: Gu, Cheng-Yuan, et al.
Publicado: (2016)

Pelvic plexus block to provide better anesthesia in transperineal template-guided prostate biopsy: a randomised controlled trial
por: Ding, Xue-fei, et al.
Publicado: (2019)

Can we improve the detection rate of prostate cancer using standard 12‐core TRUS‐guided prostate biopsy? Focused on the location of prostate biopsy
por: Yoo, Sangjun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_506igan1h42k5nim8hens9maa3